Merck & Co Inc (NYSE:MRK)
$ 130.06 -0.17 (-0.13%) Market Cap: 329.42 Bil Enterprise Value: 358.02 Bil PE Ratio: 144.51 PB Ratio: 8.16 GF Score: 88/100

Q4 2020 Merck & Co Inc Earnings Call Transcript

Feb 04, 2021 / 01:00PM GMT
Release Date Price: $72.5 (-1.67%)
Operator

Good morning. My name is Lara, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q4 Sales and Earnings Conference Call. (Operator Instructions) Thank you.

I would now like to turn the call over to Peter Dannenbaum, Vice President, Investor Relations. Sir, please go ahead.

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thank you, Lara, and good morning. Welcome to Merck's Fourth Quarter 2020 Conference Call. Today, I'm joined by Ken Frazier, our Chairman and Chief Executive Officer; Rob Davis, our Chief Financial Officer; Dr. Dean Li, President of Merck Research Labs; Frank Clyburn, our Chief Commercial Officer; and Mike Nally, our Chief Marketing Officer.

Before we get started, I'd like to point out a few items. You will see that we have items in our GAAP results such as acquisition-related charges, restructuring costs and certain other items. You should note that we have excluded these from our non-GAAP results and provide a reconciliation in our press release. We've also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot